SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kimia Biosciences - Quaterly Results

13 Feb 2025 Evaluate
The Revenue for the quarter ended  December 2024 of Rs. 300.99 millions grew by 15.12 % from Rs. 261.45 millions.The Total Profit for the quarter ended December 2024 of Rs. 45.70 millions grew from Rs.-19.52 millions Operating profit Margin for the quarter ended December 2024 improved to 54.20% as compared to -4.71% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 300.99 261.45 15.12 806.77 745.75 8.18 1048.77 1285.16 -18.39
Other Income 4.24 5.76 -26.39 8.78 13.38 -34.38 16.42 12.13 35.37
PBIDT 54.20 -4.71 -1250.74 129.50 -33.09 -491.36 11.59 -37.63 -130.80
Interest 10.08 13.11 -23.11 31.55 37.06 -14.87 50.50 42.45 18.96
PBDT 44.12 -17.82 -347.59 97.95 -70.15 -239.63 -38.91 -90.56 -57.03
Depreciation 8.16 8.19 -0.37 25.00 24.74 1.05 32.92 33.32 -1.20
PBT 35.96 -26.01 -238.25 72.95 -94.89 -176.88 -71.83 -123.88 -42.02
TAX -9.74 -6.49 50.08 -3.28 -23.85 -86.25 -18.75 -30.36 -38.24
Deferred Tax -3.57 -6.49 -44.99 -3.28 -23.85 -86.25 -18.75 -30.36 -38.24
PAT 45.70 -19.52 -334.12 76.23 -71.04 -207.31 -53.08 -93.52 -43.24
Equity 47.31 47.31 0.00 47.31 47.31 0.00 47.31 47.31 0.00
PBIDTM(%) 18.01 -1.80 -1099.57 16.05 -4.44 -461.76 1.11 -2.93 -137.74

Kimia Biosciences Share Price

36.18 0.45 (1.26%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×